78
Participants
Start Date
November 23, 2021
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Masitinib Mesylate
3CL-protease inhibitor
Placebo
Placebo
NOT_YET_RECRUITING
Intensive Care Unit, CHU Gabriel-Montpied, Clermont-Ferrand
RECRUITING
Gabrichevsky Institute of Epidemiology and Microbiology, Moscow
RECRUITING
Scientific Research Center Eco-Safety, Saint Petersburg
RECRUITING
City Clinical Hospital No. 14, Yekaterinburg
RECRUITING
Netcare Jakaranda Hospital, Pretoria
RECRUITING
Langeberg Clinical Trials, Cape Town
Lead Sponsor
AB Science
INDUSTRY